Bernard Vandercam
Impact in
- Microbiology top 0.5%
- Actinomycetales infections and treatment
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- HIV/AIDS drug development and treatment 7
- Antifungal resistance and susceptibility 3
- Antimicrobial Resistance in Staphylococcus 2
-
- Dialysis and Renal Disease Management 2
- Co-authors
- Michel Delmée (3 shared papers)Jean‐Luc Gala (3 shared papers)Pascal Vannuffel (2 shared papers)G. Wauters (3 shared papers)Jacques Gigi (3 shared papers)H Ezzedine (1 shared paper)Eric Jean Goffin (4 shared papers)V. Avesani (1 shared paper)
- Journals
- Clinical Infectious Diseases (4 papers)Antiviral Therapy (2 papers)American Journal of Kidney Diseases (1 paper)Research in Microbiology (1 paper)Journal of Clinical Microbiology (1 paper)
- Partner nations
- BelgiumFranceNetherlands
In The Last Decade
Bernard Vandercam
25 papers receiving 1.1k citations
Bernard Vandercam's Hit Papers
Peers
Comparison fields: 5 of 59
- Microbiology 154
- Infectious Diseases 723
- Clinical Biochemistry 42
- Molecular Medicine 26
- Virology 17
Countries citing papers authored by Bernard Vandercam
This map shows the geographic impact of Bernard Vandercam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Vandercam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Vandercam more than expected).
Fields of papers citing papers by Bernard Vandercam
This network shows the impact of papers produced by Bernard Vandercam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Vandercam. The network helps show where Bernard Vandercam may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernard Vandercam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 261 | |
| 2 | 1998 | 205 | |
| 3 | Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study Hit paper breakdown → | 2016 | 196 |
| 4 | 2017 | 82 | |
| 5 | 1987 | 66 | |
| 6 | Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. | 1987 | 56 |
| 7 | 1996 | 53 | |
| 8 | 1999 | 52 | |
| 9 | 2022 | 44 | |
| 10 | 1999 | 43 | |
| 11 | 2005 | 38 | |
| 12 | 2004 | 24 | |
| 13 | Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy. | 2005 | 12 |
| 14 | 2009 | 8 | |
| 15 | 2000 | 7 | |
| 16 | 2012 | 7 | |
| 17 | 1989 | 6 | |
| 18 | 2006 | 6 | |
| 19 | Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients | 1996 | 5 |
| 20 | HIV infection and rape. | 1992 | 4 |
About Bernard Vandercam
Bernard Vandercam is a scholar working on Infectious Diseases, Nephrology, Emergency Medicine, Epidemiology and Microbiology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), Antifungal resistance and susceptibility (3 papers), HIV-related health complications and treatments (2 papers), Dialysis and Renal Disease Management (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Neutropenia and Cancer Infections (2 papers), Autoimmune and Inflammatory Disorders (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Microbiology (154 citations), Infectious Diseases (723 citations), Clinical Biochemistry (42 citations), Molecular Medicine (26 citations) and Virology (17 citations). Bernard Vandercam has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Michel Delmée, Jean‐Luc Gala, Pascal Vannuffel, G. Wauters, Jacques Gigi, H Ezzedine, Eric Jean Goffin, V. Avesani, J. L. Michaux and Jacques F. G. M. Meis. Their work appears in journals such as Clinical Infectious Diseases, Antiviral Therapy, American Journal of Kidney Diseases, Research in Microbiology and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.